Studies on the etiopathogenesis of type 1 diabetes with an aim to develop preventative therapies
| Reference number | |
| Coordinator | Karolinska Institutet - Centrum för infektionsmedicin |
| Funding from Vinnova | SEK 2 206 445 |
| Project duration | May 2012 - July 2015 |
| Status | Completed |
Important results from the project
The scientific goals for this project were to identify mechanisms by which viruses trigger type 1 diabetes, and to develop a novel vaccine. The goal was also to support the academic qualification of Dr. Malin Flodström-Tullberg. At the end of the fellowship period, new mechanistical insights have been gained and a novel prototype vaccine has been developed. Dr. Flodström Tullberg has been offered a full professorship at KI and she has also taken up a visiting professorship at the Univ. of Tampere.
Expected long term effects
As expected, the research conducted during the fellowship period has yielded novel information on virus-induced diabetes as well as the development and testing of a new prototype vaccine. It has lead to the creation of a long-lasting international research collaborations. The fellowship period has also lead to the academic qualification of Dr. Flodström Tullberg, who has been offered a full professorship at the Karolinska Institute as well as a visiting professorship at the University of Tampere, Finland.
Approach and implementation
Dr. Flodström Tullberg has continued to lead her research group at Karolinska Institutet. She has also spend numerous shorter and longer time periods as visiting scientist at the University of Tampere, and continued the collaborative efforts together with Vactech Oy and the research group led by Prof. Hyöty, as well as the group lead by Assoc. Prof. Vesa Hytönen and colleagues. She has participated in numerous scientific meetings and has become a member of several important international research networks.